Cardiac Mapping Market to Surge to USD 5.5 Billion, Exhibiting a 5.8% CAGR from 2024 to 2034: TMR Analysis
01 juil. 2024 10h00 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research. Inc. , July 01, 2024 (GLOBE NEWSWIRE) -- The global cardiac mapping market stood at US$ 3 billion in 2023, and the global market is...
Anthos Therapeutics Announces ~84% of Eligible Patients Have Transitioned to Abelacimab in the AZALEA-TIMI 71 Extension Study of Atrial Fibrillation Patients at a Moderate-to-High Risk of Stroke
06 juin 2024 08h15 HE
|
Anthos Therapeutics
75% of patients in the rivaroxaban arm voluntarily switched from the once-daily oral anticoagulant to once-monthly abelacimab Landmark AZALEA-TIMI 71 Study previously stopped early due to an...
Anthos Therapeutics Announces Appointment of Bill Meury as CEO
22 avr. 2024 11h09 HE
|
Anthos Therapeutics
CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Anthos Therapeutics, Inc. (Anthos), is a clinical-stage company developing innovative therapies for cardiovascular diseases, founded by...
Irregular heartbeat can now be treated more safely and quicker than before
08 avr. 2024 12h52 HE
|
Nebraska Medicine
Omaha, Neb., April 08, 2024 (GLOBE NEWSWIRE) -- Nebraska Medicine patient Doris McCann found out something wasn't right with her heart when she got an Apple Watch for Christmas. "I started getting...
Implantable Cardiac Monitor Market Predicted to Achieve 6.6% CAGR and Valued at USD 1.6 Billion by 2031- Report by Transparency Market Research, Inc.
18 mars 2024 10h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, March 18, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. -The implantable cardiac monitor industry was worth US$ 914.5 million in 2022. By the end of...
Arrhythmia Monitoring Devices Market Size Worth USD 15.33 Billion in 2032 | Emergen Research
15 janv. 2024 07h33 HE
|
Emergen Research
Vancouver, Jan. 15, 2024 (GLOBE NEWSWIRE) -- The global arrhythmia monitoring devices market size was USD 7.43 billion in 2022 and is expected to register a rapid revenue CAGR of 7.7% during the...
Global $12.07 Bn Atrial Fibrillation Markets, 2017-2022, 2022-2027F, 2032F: Analysis, Forecasts and Competitive Landscape
26 oct. 2023 04h18 HE
|
Research and Markets
Dublin, Oct. 26, 2023 (GLOBE NEWSWIRE) -- The "Atrial Fibrillation Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global atrial fibrillation market is...
Anticoagulant Reversal Drugs Market Revenue to Cross USD 2.3 billion by 2031, Expanding at a CAGR of 11.3% - Exclusive Report by Transparency Market Research
17 oct. 2023 03h40 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global anticoagulant reversal drugs market is projected to flourish at a CAGR of 11.3%...
ZyVersa Therapeutics Announces Research Published in The Journal of Clinical Investigation Reinforcing IC 100’s Rationale for Inhibiting ASC Specks to Attenuate Spread of Inflammation into Surrounding Tissues
22 sept. 2023 06h35 HE
|
ZyVersa Therapeutics
Patients with chronic kidney disease (“CKD”) exhibit chronic systemic inflammation characterized by increased circulating levels of IL-1β, IL-6, and CRP.This study demonstrated that CKD-induced IL-1β...
Clot Busting Drugs Market to Reach $60 Billion, Globally, by 2032 at 8.2% CAGR: Allied Market Research
24 juil. 2023 09h55 HE
|
Allied Market Research
Portland,OR, July 24, 2023 (GLOBE NEWSWIRE) -- Allied Market Research has recently published a report, titled, “Clot Busting Drugs Market by Product (Thrombolytic Drugs, Anti-Platelet Drugs,...